Skip to content

Clinical use of airway clearance in children with chronic endobronchial infectious diseases

Clinical use of airway clearance in children with chronic endobronchial infectious diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065033
Enrollment
Unknown
Registered
2022-10-26
Start date
2022-10-26
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic endobronchial infectious diseases in children

Interventions

Observe the group:Airway clearance technique
Control group:Conventional treatment

Sponsors

Children affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 13 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for PBB, CSLD, BE formulated by the Expert Consensus on the Diagnosis and Treatment of Chronic Wet Cough in Chinese Children (2019 Edition); (2) Voluntary participation in this study.

Exclusion criteria

Exclusion criteria: (1) Not receiving standardized drug treatment. (2) Those who cannot cooperate to complete airway clearance. (3) There are contraindications to airway clearance, such as: recent maxillofacial surgery and trauma, suspicious or active hemoptysis, etc. (4) The presence of other systemic chronic diseases.

Design outcomes

Primary

MeasureTime frame
Daily cough score;

Secondary

MeasureTime frame
Lung function;Sputum properties;quality of life;Relapse rate;

Countries

China

Contacts

Public ContactLiu Yulin

Children affiliated to Chongqing Medical University

liuyulin817@163.com13637887663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026